On April 17, 2026, Daré Bioscience completed a closing of a Regulation A offering, issuing 20,000 Investor Units at $5.00 per unit for aggregate gross proceeds of $100,000.
Key takeaways
Daré issued 20,000 Investor Units consisting of Series A Preferred Stock and warrants to purchase common stock.
The offering price was $5.00 per Investor Unit, resulting in total gross proceeds of $100,000.
The offering was conducted pursuant to Regulation A under an offering statement qualified by the SEC on April 1, 2026.
Each Investor Unit includes one share of Series A Preferred Stock and two Investor Warrants to purchase common stock.